476 related articles for article (PubMed ID: 20460378)
1. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.
Zhou M; Liu Z; Zhao Y; Ding Y; Liu H; Xi Y; Xiong W; Li G; Lu J; Fodstad O; Riker AI; Tan M
J Biol Chem; 2010 Jul; 285(28):21496-507. PubMed ID: 20460378
[TBL] [Abstract][Full Text] [Related]
2. miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.
Kong F; Sun C; Wang Z; Han L; Weng D; Lu Y; Chen G
J Huazhong Univ Sci Technolog Med Sci; 2011 Aug; 31(4):543. PubMed ID: 21823019
[TBL] [Abstract][Full Text] [Related]
3. miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.
Chen J; Fu X; Wan Y; Wang Z; Jiang D; Shi L
Tumour Biol; 2014 Jul; 35(7):6293-302. PubMed ID: 24643683
[TBL] [Abstract][Full Text] [Related]
4. Camptothecin induces apoptosis in cancer cells via microRNA-125b-mediated mitochondrial pathways.
Zeng CW; Zhang XJ; Lin KY; Ye H; Feng SY; Zhang H; Chen YQ
Mol Pharmacol; 2012 Apr; 81(4):578-86. PubMed ID: 22252650
[TBL] [Abstract][Full Text] [Related]
5. miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance.
Liu Z; Liu H; Desai S; Schmitt DC; Zhou M; Khong HT; Klos KS; McClellan S; Fodstad O; Tan M
J Biol Chem; 2013 Feb; 288(6):4334-45. PubMed ID: 23255607
[TBL] [Abstract][Full Text] [Related]
6. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway.
Wang YD; Cai N; Wu XL; Cao HZ; Xie LL; Zheng PS
Cell Death Dis; 2013 Aug; 4(8):e760. PubMed ID: 23928699
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-16 sensitizes breast cancer cells to paclitaxel through suppression of IKBKB expression.
Tang X; Jin L; Cao P; Cao K; Huang C; Luo Y; Ma J; Shen S; Tan M; Li X; Zhou M
Oncotarget; 2016 Apr; 7(17):23668-83. PubMed ID: 26993770
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
9. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia.
Zhang H; Luo XQ; Feng DD; Zhang XJ; Wu J; Zheng YS; Chen X; Xu L; Chen YQ
Mol Cancer; 2011 Sep; 10():108. PubMed ID: 21880154
[TBL] [Abstract][Full Text] [Related]
11. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells.
Yang Q; Wang Y; Lu X; Zhao Z; Zhu L; Chen S; Wu Q; Chen C; Wang Z
Oncotarget; 2015 Feb; 6(5):3268-79. PubMed ID: 25605244
[TBL] [Abstract][Full Text] [Related]
12. [Effects of miRNA-21 on paclitaxel-resistance in human breast cancer cells].
Zhao ZL; Cai Y; Wang YY; Xia CL; Li CX; Chen SL; Yang QL; Chen CJ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 44(4):400-9. PubMed ID: 26555418
[TBL] [Abstract][Full Text] [Related]
13. miR-125b lowers sensitivity to apoptosis following mitotic arrest: Implications for breast cancer therapy.
Matuszyk J; Klopotowska D
J Cell Physiol; 2020 Oct; 235(10):6335-6344. PubMed ID: 32052874
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3.
Ao X; Nie P; Wu B; Xu W; Zhang T; Wang S; Chang H; Zou Z
Cell Death Dis; 2016 Nov; 7(11):e2463. PubMed ID: 27831559
[TBL] [Abstract][Full Text] [Related]
15. [miR-125b promotes proliferation of human acute myeloid leukemia cells by targeting Bak1].
Zeng QH; Xu L; Liu XD; Liao W; Yan MX
Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1010-4. PubMed ID: 24369155
[TBL] [Abstract][Full Text] [Related]
16. MiR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis.
Chatterjee A; Chattopadhyay D; Chakrabarti G
Cell Signal; 2015 Feb; 27(2):189-203. PubMed ID: 25435430
[TBL] [Abstract][Full Text] [Related]
17. MiR-125b protects against ethanol-induced apoptosis in neural crest cells and mouse embryos by targeting Bak 1 and PUMA.
Chen X; Liu J; Feng WK; Wu X; Chen SY
Exp Neurol; 2015 Sep; 271():104-11. PubMed ID: 26024858
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells.
Shi Y; Gong W; Lu L; Wang Y; Ren J
Braz J Med Biol Res; 2019; 52(11):e8657. PubMed ID: 31664305
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer.
Li Y; Zhang L; Dong Z; Xu H; Yan L; Wang W; Yang Q; Chen C
Pathol Res Pract; 2021 Apr; 220():153405. PubMed ID: 33756128
[TBL] [Abstract][Full Text] [Related]
20. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
